SPEC — SpectraCure AB (publ) Cashflow Statement
0.000.00%
- SEK247.69m
- SEK206.04m
- SEK2.84m
Annual cashflow statement for SpectraCure AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -13.7 | -15.4 | -23.3 | -25.4 | -20.4 |
Depreciation | |||||
Non-Cash Items | 0.02 | 2.31 | 2.68 | 3 | 3.56 |
Other Non-Cash Items | |||||
Changes in Working Capital | 1.5 | 3.69 | 2.06 | -0.578 | -1.8 |
Change in Accounts Receivable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -10.1 | -9.4 | -18.6 | -23 | -18.7 |
Capital Expenditures | -15.1 | -10.6 | -8.49 | -10.1 | -15.8 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | — | -1.23 | 0.205 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -15.1 | -10.6 | -8.49 | -11.3 | -15.6 |
Financing Cash Flow Items | -1.34 | -15.1 | 1.8 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 34.3 | 123 | -0.453 | -2.2 | -1.99 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 9.13 | 103 | -27.5 | -36.5 | -36.2 |